Healthcare Revenues LLC provides oncology medical billing services for independent oncologists, hematology-oncology groups, and outpatient cancer clinics across the United States. Our services address physician claims, chemotherapy administration, infusion coding, drug billing review, denial management, and accounts receivable follow-up.
An oncology encounter may involve a physician evaluation, chemotherapy administration, supportive infusion services, and separately billable medications.
Each component has its own documentation and reimbursement requirements. Physician-administered drugs require particular attention to HCPCS codes, billing units, and payer coverage rules.
Healthcare Revenues LLC supports oncology practices with professional claims processing and revenue cycle management based on their services and agreed billing responsibilities.
Our oncology billing support includes:
Our team reviews oncology charges against available treatment records, identifies missing billing information, and follows up on unpaid or denied claims. We work with your practice to address billing discrepancies and provide clear updates on outstanding balances and claim status.
Chemotherapy administration billing depends on the medication administered, delivery method, treatment documentation, and applicable coding rules.
Initial administration, additional services, and qualifying sequential infusions require review under the relevant CPT coding hierarchy.
Not every intravenous medication qualifies for chemotherapy administration coding. Therapeutic infusions and hydration services follow different reporting rules.
Infusion claims require accurate administration records, including start and stop times, medications, delivery routes, and services performed.
When multiple medications are administered during one encounter, coding depends on whether services are initial, sequential, or concurrent.
Documentation must also support the medical necessity of separately reported administration services.
Our coding review examines the available treatment record and claim details before submission.
Physician-administered oncology medications may be billed separately from administration services when coverage and payment rules permit.
Drug claims require accurate HCPCS Level II codes, documented dosage, and billing units consistent with the applicable code descriptor.
Certain payers also require National Drug Code information.
Incorrect drug units or mismatched documentation may lead to claim denials, underpayments, or payment disputes.
For qualifying separately payable Medicare Part B drugs supplied in single-dose containers, the JW modifier identifies eligible discarded quantities.
The JZ modifier indicates that no reportable amount was discarded.
These modifiers do not apply to every medication or billing arrangement. Documentation must support the quantity administered, any eligible discarded amount, and the applicable Medicare requirements.
Under a buy-and-bill arrangement, a practice purchases covered medications, administers them, and submits the applicable drug and administration claims.
Reimbursement delays or denied drug claims create financial exposure because the practice has already incurred acquisition costs.
Accurate drug coding, payer eligibility, authorization information, and payment follow-up are particularly important in these arrangements.
Healthcare Revenues LLC supports the billing and reimbursement administration associated with covered physician-administered medications.
Medical oncologists provide new and established patient evaluations, treatment planning, medication management, and ongoing clinical assessments.
Office and outpatient E/M code selection generally depends on documented medical decision-making or qualifying total time.
An E/M service performed on the same date as chemotherapy or infusion administration is not automatically separately payable.
When separately reported, the physician service must meet applicable requirements for a significant, separately identifiable encounter, including modifier rules where appropriate.
Hematology-oncology practices often combine physician office visits, diagnostic evaluations, medication management, and infusion-related services.
Billing must reflect the services actually performed, supported diagnoses, provider information, and payer coverage requirements.
Our medical oncology billing support includes review of professional charges and relevant treatment-related claims without treating every hematology encounter as a chemotherapy service.
Healthcare Revenues LLC helps hematology-oncology practices review charges for missing information, track claim status, and resolve payment discrepancies. Our team coordinates with practice staff to clarify documentation gaps and follows up on outstanding balances for both hematologic conditions and cancer-related care.
Coverage requirements vary by payer, medication, treatment indication, and care setting.
Eligibility review may involve insurance effective dates, benefits, patient responsibility, referral requirements, and applicable prior authorizations.
For certain oncology medications, approval may depend on diagnosis, treatment documentation, dosage, or other payer-specific criteria.
Changes in therapy or insurance coverage may require additional review.
Authorization does not guarantee reimbursement, and not every oncology service requires prior approval.
Healthcare Revenues LLC helps track authorization status, approved treatment details, and expiration dates while flagging missing information for your practice. Our team coordinates with clinic staff and payers to clarify coverage discrepancies and follow up on pending requests before scheduled treatment.
Healthcare Revenues LLC provides billing and revenue cycle support for medical oncology and hematology-oncology practices.
Review E/M encounters, administration services, drug billing information, diagnoses, and relevant modifiers.
Prepare claims using available clinical documentation, provider information, and payer billing requirements.
Record payer payments, contractual adjustments, and remaining balances from remittance information.
Investigate rejected or denied claims, prepare appropriate corrections, and support appeals when warranted.
Review aging claims, communicate with payers, and monitor unresolved physician and drug reimbursement balances.
Oncology revenue cycle management connects insurance coverage, treatment documentation, drug charge capture, claim submission, and payment follow-up.
Our workflow includes:

Examine eligibility, benefits, and applicable authorization information.

Review physician encounters, administration records, and medication details.

Check CPT, HCPCS, ICD-10-CM, drug units, and relevant modifiers.

Prepare professional claims and monitor payer responses.

Investigate correctable coding, authorization, documentation, and coverage issues.

Post remittances, review outstanding claims, and report unresolved balances.
Oncology claims may be denied because of incorrect drug units, unsupported administration codes, missing authorizations, incomplete documentation, modifier errors, or payer coverage restrictions.
Our claims management process reviews payer explanations, prepares eligible corrections or appeals, and follows up on unpaid balances.
Monitoring denial patterns also helps identify recurring issues affecting infusion, drug, and physician claims.
The Merit-based Incentive Payment System (MIPS) applies to eligible Medicare clinicians and groups.
Oncologists may have reporting responsibilities involving Quality, Cost, Improvement Activities, and Promoting Interoperability, subject to applicable participation and category reweighting rules.
Eligibility depends on Medicare enrollment, service volume, clinician type, and reporting arrangements. Not every oncologist is required to participate.
Healthcare Revenues LLC provides MIPS consulting support involving eligibility review, measure selection guidance, documentation review, and reporting assistance where applicable.
Healthcare Revenues LLC provides medical billing, coding, revenue cycle management, and MIPS consulting services for U.S. healthcare organizations.
Our oncology billing approach emphasizes:
Physician encounters, chemotherapy administration, and infusion claims.
HCPCS units, documented doses, and applicable wastage modifiers.
Coverage, medical necessity, and authorization information.
Denial investigation, corrections, appeals, and outstanding balances.
Communication regarding unresolved reimbursement issues.
Review of payer payments, contractual adjustments, and potential underpayments.
They include coding review, professional claim submission, payment posting, denial management, and accounts receivable follow-up for oncology physician and treatment-related services.
Claims use applicable administration codes based on the medication, delivery method, documented service, and relevant coding hierarchy.
Qualifying physician-administered drugs are reported using applicable HCPCS codes, supported dosage documentation, and accurate billing units.
For qualifying Medicare Part B single-dose drugs, JW identifies eligible discarded amounts, while JZ indicates that no reportable amount was discarded.
Requirements vary by payer, drug, diagnosis, and treatment setting. Not every oncology service requires prior authorization.
Yes. Practices may outsource agreed coding review, claim submission, payment posting, denial management, and accounts receivable activities.
Not all oncologists are required to report. CMS determines eligibility based on clinician type, Medicare enrollment, service volume, and participation arrangements.
From chemotherapy administration and drug claims to physician billing, denial management, and accounts receivable follow-up, Healthcare Revenues LLC will review your practice’s requirements and discuss the billing and RCM services appropriate for your organization.